Ongoing genomic surveillance shows no SARS-CoV-2 variant has met the criteria for designation as a variant of concern since early Omicron lineages years ago, with health agencies classifying recent sublineages like BA.3.2 only as variants under monitoring due to limited evidence of heightened severity or transmissibility. Widespread population immunity from prior infections and updated vaccines continues to limit the impact of mutations in dominant circulating strains such as XFG and NB.1.8.1 sublineages. With just months remaining before 2027 and no rapid escalation signals in wastewater or clinical data, traders assign an overwhelming 91% probability to no new variant of concern emerging, consistent with the virus's recent evolutionary pattern within established Omicron families.